The mevalonate (MVA)/cholesterol pathway is crucial for central nervous system (CNS) development and function and consequently, any dysfunction of this fundamental metabolic pathway is likely to provoke pathologic changes in the brain. Mutations in genes directly involved in MVA/cholesterol metabolism cause a range of diseases, many of which present neurologic and psychiatric symptoms. This raises the question whether other diseases presenting similar symptoms are related albeit indirectly to the MVA/cholesterol pathway. Here, we summarized the current literature suggesting links between MVA/cholesterol dysregulation and specific diseases, namely autism spectrum disorder and Rett syndrome.
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3390/ijms20133317|
|Codice identificativo ISI:||WOS:000477041100201|
|Codice identificativo Scopus:||2-s2.0-85069301893|
|Titolo:||Loss of mevalonate/cholesterol homeostasis in the brain: A focus on autism spectrum disorder and rett syndrome|
|Appare nelle tipologie:||1.1 Articolo in rivista|